Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
•
Geriatric Medicine
At what age and how often do you screen for osteoporosis in non-ambulatory (e.g. developmentally disabled) young adults without other risk factors?
Related Questions
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?
Would you use a parathyroid hormone analog for treatment of osteoporosis in a patient with mildly elevated AlkPhos of unclear etiology?
What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?
Do you routinely prescribe vitamin D to reduce the risk of fall-related fractures in elderly patients regardless of their serum levels?
Would you start romosozumab in an active smoker?
Do you recommend initiating zoledronic acid for osteoporosis at the time of hospitalization for a fracture?
What is the recommended duration of Burosumab therapy for treating X-linked hypophosphatemia and how is response to therapy monitored?
When interpreting a 24-hour urinary calcium, which is more accurate: 24 hour urine calcium (mg/day) or 24-hour calcium-to-creatinine ratio (mg/g)?
What is your approach to IV fluid management for the treatment of hypercalcemia of malignancy?
